The strongest data that ties TLR9 activation to NASH disease is data from the Sanyal lab that directly associates TLR9 activation with NASH and fibrosis disease severity in human patients. The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatohepatitis.